Peptide Database/Growth Hormone Peptides

Growth Hormone Peptides

Growth hormone secretagogues stimulate natural GH production. CJC-1295 and Ipamorelin are typically stacked together, while Sermorelin and Tesamorelin offer alternative GHRH pathways.

Growth hormone secretagogues and releasing peptides are studied for their effects on endogenous GH release, IGF-1 levels, body composition, sleep quality, and recovery. Unlike exogenous HGH, these peptides work through the body’s own pulsatile release pathways, which is why IGF-1 is the primary biomarker tracked alongside fasting glucose and HbA1c.

1 growth hormone peptides with dosing guides, mechanisms, and price comparison.

CJC-1295/Ipamorelin

CJC-1295 with Ipamorelin

CJC-1295 and Ipamorelin are the two most widely studied GH secretagogues in research peptide protocols, and are almost always run together. CJC-1295 binds the GHRH receptor to amplify the growth hormone pulse, while Ipamorelin binds the ghrelin receptor to selectively trigger release without affecting cortisol or prolactin. Research dosing is typically 200–400mcg subcutaneously before bed, in 8–12 week cycles. IGF-1 is the primary response biomarker, and researchers monitor fasting glucose, insulin, and HbA1c to catch any early signs of insulin resistance.

Typical dose

300mcg

Cycle

8-12 weeks

Profile Prices Calculator

Popular Growth Hormone Peptide Comparisons

Ipamorelin vs CJC-1295 CJC-1295 vs Sermorelin MK-677 vs Ipamorelin Sermorelin vs Ipamorelin GHRP-2 vs GHRP-6

In-depth guide

Best Peptides for Muscle Growth

Build a Growth Hormone protocol

Combine growth hormone peptides into a tracked protocol with blood work milestones at baseline, mid-cycle, and post-cycle.

Build Your Protocol

This platform provides informational tools only, not medical advice. Information is for educational purposes only. Consult a licensed provider.